NSD2 and neoplasm: Another interesting aspect that emerged from this study was the ability of NSD proteins, such as NSD2, to methylate non-histone substrates, in this case CD147, which can in a histone-modification-independent manner play a decisive role in controlling anti-tumor immunity.